Article
Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses.
American journal of respiratory and critical care medicine - 1 Jun 1996
Zhu J, Kaplan A M, Goud S N
Abstract excerpt
Among the side effects of bleomycin (BLM), a drug frequently used in the treatment of lymphomas and squamous-cell carcinomas, is pneumonitis with pulmonary fibrosis. The most prominent biochemical lesion associated with pulmonary fibrosis, a chronic debilitating and sometimes fatal disease, is an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
